‘I expect more bold initiatives on macro-economic front’
Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates
The Modi Government has been following a policy of concentrating on macro…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
‘Funding for pharma companies might be a way to move forward’
Dr Dinesh Dua, Chairman,Pharmexcil, Chairman, Entrepreneurship & Start Ups, CII North India,CEO & Director, Nectar…
‘There is a definite need to support SME upgradation’
Harish Jain, Secretary and Sunil Attavar, President, Karnataka Drugs & Pharmaceuticals Manufacturer’s Association
There is no…
‘We expect the new govt to reduce regulatory intervention’
BR Sikri, Chairman, Fope
First let me highlight the good things done by the present government.:
Recently agreed to publish SQ…
A report card and a wishlist
Demonetisation, Swachh Bharat Abhiyan, Make in India, Digital India, Ayushmaan Bharat and implementation of GST have been the…
Price cap on onco drugs: Will it have the desired impact?
NPPA’s recent move to cap the price of 42 non-scheduled cancer drugs has evoked mixed reactions from the industry. While some…
Honesty is still the best policy!
Amit Rajan, Managing Director, Prosfora Technologies, says that instilling a culture of compliance in a pharma set up is about…
How to build a quality culture to meet GMP compliance?
In order to maintain a quality culture, Rajashri Survase-Ojha, Founder and MD, RAAJ GPRAC advises that organisations must maintain…
Upgrading knowledge and skills in cost-effective manner
Rahul Guha, Partner and Director and India Lead, Healthcare Practice, BCG, gives an insight on identifying possible areas of…
Quality: From compliance to culture
As custodians to ensure patient safety, quality teams in pharma firms must have a mechanism not only to comply but to consistently…